Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Goodwill & Intangibles (2016 - 2021)

Historic Goodwill & Intangibles for Assembly Biosciences (ASMB) over the last 7 years, with Q3 2021 value amounting to $41.6 million.

  • Assembly Biosciences' Goodwill & Intangibles changed 0.0% to $41.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was $41.6 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $41.6 million for FY2020, which is 0.0% changed from last year.
  • Per Assembly Biosciences' latest filing, its Goodwill & Intangibles stood at $41.6 million for Q3 2021, which was down 0.0% from $41.6 million recorded in Q2 2021.
  • In the past 5 years, Assembly Biosciences' Goodwill & Intangibles ranged from a high of $41.6 million in Q1 2017 and a low of $41.6 million during Q4 2017
  • Its 5-year average for Goodwill & Intangibles is $41.6 million, with a median of $41.6 million in 2017.
  • Within the past 5 years, the most significant YoY rise in Assembly Biosciences' Goodwill & Intangibles was 0.0% (2017), while the steepest drop was 0.03% (2017).
  • Over the past 5 years, Assembly Biosciences' Goodwill & Intangibles (Quarter) stood at $41.6 million in 2017, then changed by 0.0% to $41.6 million in 2018, then changed by 0.0% to $41.6 million in 2019, then changed by 0.0% to $41.6 million in 2020, then changed by 0.0% to $41.6 million in 2021.
  • Its Goodwill & Intangibles was $41.6 million in Q3 2021, compared to $41.6 million in Q2 2021 and $41.6 million in Q1 2021.